{"filing":{"accession_number":"0001437749-26-021844","cik":"0000039368","ticker":"FUL","company_name":"FULLER H B CO","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ful20260625_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/39368/000143774926021844/ful20260625_8k.htm"},"events":[{"id":14294,"run_id":12718,"accession_number":"0001437749-26-021844","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), with boards of both companies having reached agreement. The transaction includes approximately $3 billion in committed bridge financing, is expected to add ~$300 million in annual revenues with ~$55 million in run-rate synergies, and is subject to shareholder approval and regulatory clearance with expected close by year-end 2026.","company_name":"FULLER H B CO","ticker":"FUL","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11675,"accession_number":"0001437749-26-021844","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), with boards of both companies having reached agreement on terms. The filing discloses entry into a Co-operation Agreement and Bridge Credit Agreements totaling approximately $3 billion in committed financing. This is a material acquisition transaction expected to close by end of 2026, representing a significant strategic expansion into medical adhesives with ~$55 million in expected synergies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:34:19.742426+00:00","company_name":"","ticker":null,"filing_date":""},{"id":11676,"accession_number":"0001437749-26-021844","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), representing a material acquisition that will increase revenues by approximately $300 million and is expected to close by year-end. The Item 2.03 disclosure incorporates by reference the financing details from Item 1.01, confirming this is the creation of a direct financial obligation tied to the M\u0026A transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:34:19.742426+00:00","company_name":"","ticker":null,"filing_date":""},{"id":11677,"accession_number":"0001437749-26-021844","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), representing a material acquisition that will increase the company's TAM by $15 billion and add approximately $300 million in annual revenues. The transaction is subject to shareholder approval and regulatory clearance, with expected close by year-end 2026, and is expected to deliver ~$55 million in run-rate synergies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:34:19.742426+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11675,"accession_number":"0001437749-26-021844","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), with boards of both companies having reached agreement on terms. The filing discloses entry into a Co-operation Agreement and Bridge Credit Agreements totaling approximately $3 billion in committed financing. This is a material acquisition transaction expected to close by end of 2026, representing a significant strategic expansion into medical adhesives with ~$55 million in expected synergies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:34:19.742426+00:00","company_name":"FULLER H B CO","ticker":"FUL","filing_date":"2026-06-26"},{"id":11676,"accession_number":"0001437749-26-021844","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), representing a material acquisition that will increase revenues by approximately $300 million and is expected to close by year-end. The Item 2.03 disclosure incorporates by reference the financing details from Item 1.01, confirming this is the creation of a direct financial obligation tied to the M\u0026A transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:34:19.742426+00:00","company_name":"FULLER H B CO","ticker":"FUL","filing_date":"2026-06-26"},{"id":11677,"accession_number":"0001437749-26-021844","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"H.B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group plc for £2.85 per share (£715 million enterprise value), representing a material acquisition that will increase the company's TAM by $15 billion and add approximately $300 million in annual revenues. The transaction is subject to shareholder approval and regulatory clearance, with expected close by year-end 2026, and is expected to deliver ~$55 million in run-rate synergies.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:34:19.742426+00:00","company_name":"FULLER H B CO","ticker":"FUL","filing_date":"2026-06-26"}]}